Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 23;6(3):rkac069.
doi: 10.1093/rap/rkac069. eCollection 2022.

Comment on: Benchmarking tocilizumab use for giant cell arteritis

Affiliations

Comment on: Benchmarking tocilizumab use for giant cell arteritis

Shalini Janagan et al. Rheumatol Adv Pract. .
No abstract available

PubMed Disclaimer

Comment in

  • doi: 10.1093/rap/rkac037

References

    1. Conway R, Putman MS, Mackie SL.. Benchmarking tocilizumab use for giant cell arteritis. Rheumatol Adv Pract 2022;6:rkac037. - PMC - PubMed
    1. Cronin O, Preston H, Fahmy H. et al. Tocilizumab for the treatment of giant cell arteritis in Scotland: a report on behalf of the Scottish Society for Rheumatology standards subgroup. Rheumatol Adv Pract 2022;6:rkac017. - PMC - PubMed
    1. Castañeda S, Prieto-Peña D, Vicente-Rabaneda EF. et al. Advances in the treatment of giant cell arteritis. J Clin Med 2022;11:1588. - PMC - PubMed
    1. Hellmich B, Agueda A, Monti S. et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79:19–30. - PubMed
    1. Liddle J, Bartlam R, Mallen CD. et al. What is the impact of giant cell arteritis on patients’ lives? A UK qualitative study. BMJ Open 2017;7:e017073. - PMC - PubMed

LinkOut - more resources